-
crossref
Kent Layne Oots
2017-02-08T11:30:17Z
置信度 0.70
-
crossref
2003-07-12T02:16:19Z
置信度 0.70
-
crossref
D.K. Pitts, J. Marwah
2002-12-14T14:42:57Z
置信度 0.70
-
crossref
David A. Gugin
2017-02-08T11:27:51Z
置信度 0.70
-
crossref
Joseph Losco
2017-02-08T11:26:30Z
置信度 0.70
-
crossref
Elina Brauna-Morzevska, Biruta Bankina, Janis Kaneps
2020-03-16T21:59:40Z
置信度 0.70
-
crossref
Francis A. Boyle
2017-02-08T11:29:42Z
置信度 0.70
-
europepmc
2027
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Breathing, eating, and talking (BET) impairments are common yet frequently underrecognized features of movement disorders. Deficits in respiration, swallowing, voice, and speech may emerge early in the course of a disease, adversely affecting safety, participa…
pubmed
Dean J, O'Flynn LC, Ciucci M, Fox C 等
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Milk-derived extracellular-vesicles (mEVs) have emerged as a promising natural nanocarriers for nutraceutical and therapeutic applications, owing to their rich cargo of bioactive proteins, lipids, microRNAs, and metabolites, coupled with their inherent biocomp…
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
The prevalence of autism spectrum disorder (ASD) has risen over the decades, reflecting improved awareness and evolving diagnostic practice. ASD is characterized by clinical and biological heterogeneity, with diverse genetic and environmental risk factors conv…
pubmed
Martinez Olondo P, de Kerchove d'Exaerde A
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Antimicrobial resistance (AMR) disproportionately affects low- and middle-income countries (LMICs). Bangladesh has adopted a National Action Plan (2023-2028) yet exemplifies the persistent gap between pharmaceutical policy frameworks and frontline antimicrobia…
pubmed
Chowdhury SM, Ukuhor H, Elshenawy RA
2026
置信度 0.82
-
Chronic primary low back pain (LBP) is a costly and disabling condition, with complex interacting factors contributing to pain experience and disability. Although multimodal therapy, including physiotherapy, behavioural therapy/psychotherapy and education is r…
pubmed
Schäfer A, Kaiser U, Elser A, Kopkow C 等
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
In recent years, pain has become a common and emergent complication in patients with β-thalassemia major. This systematic review investigates the assessment and management of pain in patients with β-thalassemia major. The Medline (via PubMed), Coch…
pubmed
Ahmadian B, Ramezani M
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
This review aimed to systematically evaluate the effects of pharmacological interventions on body composition outcomes and lifestyle intervention as background therapy in patients with acquired hypothalamic obesity (aHO).
pubmed
Yu H, Wang J, Yin M, Ji L 等
2026
置信度 0.82
-
Ergothioneine (ERG) is a naturally occurring sulfur-containing histidine derivative that has attracted considerable attention because of its exceptional chemical stability, tissue selective accumulation and potential health-promoting properties. Although human…
pubmed
Yan J, Dong H, Hao J, Ma Y 等
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
ObjectiveWith increasing emphasis on value-based healthcare and rising costs, it is essential to assess the economic impact of artificial intelligence (AI). This study systematically reviews the evidence on the cost-effectiveness of AI applications in healthca…
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
The endoplasmic reticulum-Golgi intermediate compartment (ERGIC) is a dynamic membrane system at the ER-Golgi interface, traditionally viewed as a transient station for COPII- and COPI-dependent trafficking. Emerging evidence redefines the ERGIC as a stress-re…
pubmed
Guo Y, Zheng J, Liu L, Li S 等
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Aging is a complex biological process governed by conserved genetic and metabolic pathways. Increasing evidence has identified the gut microbiota as a critical modulator of host aging and healthspan. The Caenorhabditis elegans model provides a powerful system …
pubmed
Liu Q, Tang H
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80
-
Iatrogenic blood loss contributes substantially to anemia and transfusion exposure in preterm infants. The effectiveness of interventions aimed at minimizing blood sampling remains unclear. Most prior trials have focused on placental transfusion strategies rat…
pubmed
Nissimov S, Sibrecht G, Weerasekara I, Bartocci M 等
2026
置信度 0.82
-
europepmc
2026
置信度 0.80
-
europepmc
2026
置信度 0.80